Ji Guo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ji Guo

Showing results (321-330 of 323) with videos related to

Pageof 33

Sort By:

You have reached the last page of results.This site can display upto 323 results.

Frontiers in Oncology|March 13, 2023

Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, et al.

Nature Communications|June 27, 2022

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.

Signal Transduction and Targeted Therapy|January 3, 2023

Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.

Pageof 33

Search research articles

Showing results (321-330 of 323) with videos related to

Sort By:

Pageof 33

You have reached the last page of results.This site can display upto 323 results.

Frontiers in Oncology|March 13, 2023

Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, et al.

Nature Communications|June 27, 2022

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.

Signal Transduction and Targeted Therapy|January 3, 2023

Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trialNawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.

Pageof 33